- Industry Size (2022)
- US$ 1.86 Bn
- Forecast (2032)
- CAGR
- 7% - 9%(2022 to 2032)
Synbiotic Market Overview (2022-2032)
[250 Pages Report] The global synbiotic demand is forecast to increase at a healthy CAGR of around 7% to 9% between 2022 and 2032, totaling over US$ 1.86 Billion by 2032. Growth in the market is driven by the rising application of synbiotics across various industries such as food & beverages, pharmaceuticals, and animal feed, owing to their various nutritional and health benefits.
|
Report Attribute |
Details |
|
Synbiotic Market Anticipated Forecast Value (2032) |
US$ 1.86 Billion |
|
Synbiotic Market Projected Growth Rate (2022-2032) |
7% - 9% CAGR |
Synbiotics are food ingredients or dietary supplements containing probiotic and prebiotics in the form of synergism. They are believed to inhibit the growth of pathogenic bacteria in the gut while at the same time enhancing the growth of beneficial organisms.
Probiotics are beneficial bacteria that enhance gut health while prebiotics are indigestible substrates that aid and promote the growth of friendly bacteria.
Over the last few years synbiotics and other functional foods have become essential tools for enhancing human and animal health as well as for preventing diseases. Various studies have indicated that the combination of prebiotics and probiotics may reduce the risk associated with intestinal diseases and eliminate specific microbial disorders.
Synbiotics help to boost the proper functioning of digestive system and thus improve the overall human and animal health. They are also used to improve absorption of nutrients such as calcium, phosphorus, and magnesium, and to treat hepatic and cardiovascular conditions.
Rising adoption of synbiotics across pharmaceutical, aquaculture and pet food industries is generating lucrative growth prospects within the global synbiotic market and the trend is likely to continue in the future. They are often used in aquaculture to facilitate the fish development and enhance their immune system. Similarly, they find application in pharmaceuticals and pet foods due to their various nutritional and health benefits.
Growing consumer inclination towards nutritional supplements and functional foods for improving health will continue to boost the sales of synbiotics during the forecast period. People across countries like the United States, United Kingdom, China, and Germany consume large amounts of functional foods and beverages to improve their gut health and minimize the threat of infections.
Which Factors Determine the Growth of Synbiotic Market?
Rising consumer awareness about the nutritional and health benefits of synbiotics, bourgeoning demand for functional and convenience food products, and increasing prevalence of digestive and cardiovascular disorders are some of the major factors driving the global synbiotic market.
Synbiotics have become the safest and most effective solutions for combating specific bacterial pathogens and enhancing the gut health. With rising awareness about the benefits of functional ingredients like synbiotics, people are increasingly consuming large amounts of functional foods and supplements.
Synbiotic is used as a functional ingredient in food products, which has a digestion-resistant quality. In fact, most of the functional foods and beverages used today are being fortified with synbiotics (prebiotics and probiotics). Rising consumption of these functional foods and beverages will therefore continue to push the sales of synbiotics during the forecast period.
Moreover, growing demand for dietary supplements, animal feeds, and dairy products in countries like China and India is expected to have a strong effect on the synbiotics market during the forecast period.
Synbiotics are being increasingly used in the food industry for manufacturing food products such as nutrient supplements, candies, chocolates, and several other functional foods. Increasing use of synbiotics in food processing industry will continue to provide a major impetus to market growth in the future.
Similarly, the pharmaceutical industry is expected to accrue significant benefits to the global synbiotic market. Synbiotics have become an integral part of various medicines used to treat digestive and cardiovascular conditions.
What are the Challenges Faced by the Synbiotic Industry?
Although synbiotics have multiple benefits, there are numerous obstacles that are likely to pose a challenge to market growth. Some of these factors are the high manufacturing costs of synbiotics, shortage of raw materials and lack of awareness among some regions of developing and underdeveloped regions.
Why is Europe Considered as a Prominent Market for Synbiotics?
Currently, Europe remains the most dominant market for synbiotics and the trend is likely to continue during the forecast period, owing to high awareness levels of consumers about benefits of synbiotics, presence of leading market players, and growing popularity of functional foods and supplements across countries like the U.K. and Germany.
Similarly, increasing prevalence of digestive and cardiovascular disorders is playing a crucial role in expanding the size of synbiotics market across Europe. People are consuming large amounts of synbiotic based functional foods, medicines and beverages to improve their health and tackle various disorders.
How Will Growth Unfold Across Asia Pacific?
According to Future Market Insights, Asia Pacific market is poised to grow at a relatively faster CAGR over the forecast period, owing to the growing consumer awareness regarding the benefits of synbiotics, rapid expansion of functional food market, and presence of both regional and international market players.
Rising health issues across nations like China and India has prompted manufacturer of foods & beverages, animal feeds and dairy products to add synbiotics to their products. This will continue to act as a catalyst for the growth of synbiotic market in the future.
Market Competition
Some of the key participants present in the global synbiotic market include Pfizer Pharmaceuticals, Groupe Danone, Sabinsa Corporation, Yakult Pharmaceuticals, Behn Mayer & Company Private Limited, Skystone Feed Corporation Limited, Chr. Hansen, and Daflorn MLMS Limited.
Attributed to the presence of a large number of regional and domestic participants, the market is highly competitive in nature. Leading players are continually adopting various growth strategies such as new product development, mergers, expansions and partnerships to gain a competitive edge in the market.
Scope of Report
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 7% - 9% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2015-2020 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in USD Million and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Profiled in the Synbiotic Industry Survey
By Form:
- Powder
- Liquid
By Application:
- Food & Beverages
- Pharmaceutical
- Dairy Industry
- Animal Feed
- Aquaculture Farming
By Distribution Channel:
- Direct/B2B
- Indirect/B2C
- Online Retail
- Hypermarkets/Supermarkets
- Convenience Stores
- Retail Stores
- Others
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- APEJ
- Japan
- Middle East & Africa
Frequently Asked Questions
At what rate will the synbiotic market grow until 2032?
FMI projects the global synbiotic market to expand at a CAGR of around 7% to 9% by 2032
Which regions is expected to offer maximum growth opportunities for market players?
As per FMI, Asia Pacific is anticipated to emerge as the most opportunistic market for synbiotics during the forecast period.
Which are some prominent synbiotic manufacturers?
Pfizer Pharmaceuticals, Groupe Danone, Sabinsa Corporation, Yakult Pharmaceuticals, and Behn Mayer & Company Private Limited are some prominent synbiotic manufacturers
Preview the report firsthand - request a free sample
Get SampleGet the brochure for pricing and purchase details.
Get PDFTable of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Synbiotic Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (MT) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Synbiotic Market Analysis 2017-2021 and Forecast 2022-2032, By Product Form
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Product Form, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Product Form, 2022-2032
5.3.1. Dry
5.3.2. Liquid
5.4. Y-o-Y Growth Trend Analysis By Product Form, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Form, 2022-2032
Deep-dive segmentation will be available in the sample on request
6. Global Synbiotic Market Analysis 2017-2021 and Forecast 2022-2032, By End Use
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By End Use , 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By End Use , 2022-2032
6.3.1. Food and Beverages
6.3.2. Animal Feed
6.3.3. Dietary Supplements
6.3.4. Pet Food
6.3.5. Store Based Retailing
6.4. Y-o-Y Growth Trend Analysis By End Use , 2017-2021
6.5. Absolute $ Opportunity Analysis By End Use , 2022-2032
Deep-dive segmentation will be available in the sample on request
7. Global Synbiotic Market Analysis 2017-2021 and Forecast 2022-2032, By Ingredient Type
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Ingredient Type, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Ingredient Type, 2022-2032
7.3.1. Prebiotic
7.3.2. Probiotic
7.4. Y-o-Y Growth Trend Analysis By Ingredient Type, 2017-2021
7.5. Absolute $ Opportunity Analysis By Ingredient Type, 2022-2032
Deep-dive segmentation will be available in the sample on request
8. Global Synbiotic Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) & Volume (MT) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) & Volume (MT) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia & Pacific
8.3.6. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Synbiotic Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product Form
9.2.3. By End Use
9.2.4. By Ingredient Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Form
9.3.3. By End Use
9.3.4. By Ingredient Type
9.4. Key Takeaways
10. Latin America Synbiotic Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Mexico
10.2.1.2. Brazil
10.2.1.3. Rest of Latin America
10.2.2. By Product Form
10.2.3. By End Use
10.2.4. By Ingredient Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Form
10.3.3. By End Use
10.3.4. By Ingredient Type
10.4. Key Takeaways
11. Europe Synbiotic Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. BENELUX
11.2.1.7. Russia
11.2.1.8. Rest of Europe
11.2.2. By Product Form
11.2.3. By End Use
11.2.4. By Ingredient Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Form
11.3.3. By End Use
11.3.4. By Ingredient Type
11.4. Key Takeaways
12. East Asia Synbiotic Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product Form
12.2.3. By End Use
12.2.4. By Ingredient Type
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Form
12.3.3. By End Use
12.3.4. By Ingredient Type
12.4. Key Takeaways
13. South Asia & Pacific Synbiotic Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. ASEAN
13.2.1.3. Australia and New Zealand
13.2.1.4. Rest of South Asia & Pacific
13.2.2. By Product Form
13.2.3. By End Use
13.2.4. By Ingredient Type
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Form
13.3.3. By End Use
13.3.4. By Ingredient Type
13.4. Key Takeaways
14. MEA Synbiotic Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) & Volume (MT) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) & Volume (MT) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. Turkey
14.2.1.3. South Africa
14.2.1.4. Rest of MEA
14.2.2. By Product Form
14.2.3. By End Use
14.2.4. By Ingredient Type
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Form
14.3.3. By End Use
14.3.4. By Ingredient Type
14.4. Key Takeaways
15. Key Countries Synbiotic Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Product Form
15.1.2.2. By End Use
15.1.2.3. By Ingredient Type
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Product Form
15.2.2.2. By End Use
15.2.2.3. By Ingredient Type
15.3. Mexico
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Product Form
15.3.2.2. By End Use
15.3.2.3. By Ingredient Type
15.4. Brazil
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Product Form
15.4.2.2. By End Use
15.4.2.3. By Ingredient Type
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Product Form
15.5.2.2. By End Use
15.5.2.3. By Ingredient Type
15.6. Italy
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Product Form
15.6.2.2. By End Use
15.6.2.3. By Ingredient Type
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Product Form
15.7.2.2. By End Use
15.7.2.3. By Ingredient Type
15.8. U.K.
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Product Form
15.8.2.2. By End Use
15.8.2.3. By Ingredient Type
15.9. Spain
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Product Form
15.9.2.2. By End Use
15.9.2.3. By Ingredient Type
15.10. BENELUX
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Product Form
15.10.2.2. By End Use
15.10.2.3. By Ingredient Type
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Product Form
15.11.2.2. By End Use
15.11.2.3. By Ingredient Type
15.12. China
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Product Form
15.12.2.2. By End Use
15.12.2.3. By Ingredient Type
15.13. Japan
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Product Form
15.13.2.2. By End Use
15.13.2.3. By Ingredient Type
15.14. South Korea
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Product Form
15.14.2.2. By End Use
15.14.2.3. By Ingredient Type
15.15. India
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Product Form
15.15.2.2. By End Use
15.15.2.3. By Ingredient Type
15.16. ASEAN
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Product Form
15.16.2.2. By End Use
15.16.2.3. By Ingredient Type
15.17. Australia and New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Product Form
15.17.2.2. By End Use
15.17.2.3. By Ingredient Type
15.18. GCC Countries
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Product Form
15.18.2.2. By End Use
15.18.2.3. By Ingredient Type
15.19. Turkey
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Product Form
15.19.2.2. By End Use
15.19.2.3. By Ingredient Type
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Product Form
15.20.2.2. By End Use
15.20.2.3. By Ingredient Type
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product Form
16.3.3. By End Use
16.3.4. By Ingredient Type
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Sabinsa Corporation
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Regular Girl
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. HUM Nutrition Inc.
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Enviromedica
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Viva 5 Corporation
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Seed Health, Inc.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Farnam Companies, Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Vetafarm
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Viridian Nutrition
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. HealthPlato
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. Daflorn MLM5 Ltd.
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. Chr. Hansen A/S
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
17.1.13. Skystone Feed Co. Ltd.
17.1.13.1. Overview
17.1.13.2. Product Portfolio
17.1.13.3. Profitability by Market Segments
17.1.13.4. Sales Footprint
17.1.13.5. Strategy Overview
17.1.13.5.1. Marketing Strategy
17.1.13.5.2. Product Strategy
17.1.13.5.3. Channel Strategy
17.1.14. Hedley Enterprises Ltd.
17.1.14.1. Overview
17.1.14.2. Product Portfolio
17.1.14.3. Profitability by Market Segments
17.1.14.4. Sales Footprint
17.1.14.5. Strategy Overview
17.1.14.5.1. Marketing Strategy
17.1.14.5.2. Product Strategy
17.1.14.5.3. Channel Strategy
17.1.15. Yakult Pharmaceutical Industry Co., Ltd.
17.1.15.1. Overview
17.1.15.2. Product Portfolio
17.1.15.3. Profitability by Market Segments
17.1.15.4. Sales Footprint
17.1.15.5. Strategy Overview
17.1.15.5.1. Marketing Strategy
17.1.15.5.2. Product Strategy
17.1.15.5.3. Channel Strategy
17.1.16. Pfizer Inc.
17.1.16.1. Overview
17.1.16.2. Product Portfolio
17.1.16.3. Profitability by Market Segments
17.1.16.4. Sales Footprint
17.1.16.5. Strategy Overview
17.1.16.5.1. Marketing Strategy
17.1.16.5.2. Product Strategy
17.1.16.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
